Multidisciplinary care is reshaping pituitary adenoma treatment

Dr. Mohana Rao Patibandla says pituitary adenoma care is moving beyond a surgery-first model toward personalized, team-based treatment that better protects vision, hormones and quality of life. The shift, highlighted through his international research and practice in India, underscores why early evaluation and long-term follow-up matter for patients with complex pituitary tumors.

Why it matters: - Pituitary adenomas can affect vision, hormones, fertility, metabolism and overall health, so treatment decisions can have lasting effects beyond tumor control. - A multidisciplinary approach can reduce the risk of unnecessary surgery and better match treatment to the patient’s tumor type, symptoms and long-term goals. - Personalized care matters because early treatment can help prevent permanent visual or hormonal damage.

What happened: - Dr. Mohana Rao Patibandla, founder and chief neurosurgeon of Dr. Rao's Hospital – International Institute of Neurosciences in Guntur, Andhra Pradesh, is highlighting how multidisciplinary care is changing pituitary adenoma treatment. - Dr. Rao says the key shift is not just better technology, but better clinical decision-making based on evidence and collaboration across specialties. - Dr. Rao’s hospital uses a team model that includes neurosurgery, endocrinology, neuro-ophthalmology, neuroimaging, pathology, anesthesiology, rehabilitation and long-term follow-up. - Dr. Rao says not every pituitary adenoma needs brain surgery.

The details: - Pituitary adenomas are among the most common benign brain tumors and are most often diagnosed in adults ages 30 to 60. - The pituitary gland regulates hormones that affect growth, thyroid function, adrenal function, fertility, menstrual cycles, sexual health, bone strength and overall well-being. - Symptoms can include persistent headaches, progressive peripheral vision loss, double vision, unexplained hormonal abnormalities, irregular menstrual cycles, infertility, erectile dysfunction, enlarged hands or feet, easy bruising, fatigue, thirst, urination and milk discharge unrelated to pregnancy. - Some tumors are functioning adenomas that produce excess hormones such as growth hormone, prolactin or ACTH. - Other tumors are non-functioning adenomas that mainly cause symptoms through size and pressure. - Treatment options can include endoscopic transnasal pituitary surgery, medication, hormone replacement, stereotactic radiosurgery, observation with regular MRI scans and long-term endocrine monitoring. - Stereotactic radiosurgery is not traditional surgery and involves no incision, no stitches, no bone removal and no prolonged hospitalization. - Radiosurgery may be used for residual tumor after surgery, recurrent adenomas, persistent hormone overproduction, tumors not suited for repeat surgery and selected poor surgical candidates. - International research has linked earlier evaluation and smaller tumor size at presentation with better visual recovery after transsphenoidal surgery. - Internationally published research involving Dr. Rao found that MRI alone cannot always reliably predict pituitary tumor consistency before surgery. - Dr. Rao’s research collaborations have included work on stereotactic radiosurgery for acromegaly, Cushing’s disease and Nelson’s syndrome, plus studies of surgical outcomes and visual recovery. - Dr. Rao says he worked in U.S. fellowship programs where neurosurgeons, endocrinologists, radiation oncologists, neuro-ophthalmologists, neuroradiologists and neuropathologists jointly reviewed complex pituitary cases before treatment decisions were made. - Dr. Rao’s hospital also lists advanced neuroimaging, endoscopic skull base surgery, minimally invasive neurosurgery, endovascular neurosurgery, neurocritical care, neurorehabilitation and endocrinology collaboration as part of its services. - The hospital is located at 12-19-67, Old Bank Road, Kothapet, beside AK Biryani Point, Guntur, Andhra Pradesh 522001, India. - The hospital’s website is the official hospital website.

Between the lines: - The push toward multidisciplinary care reflects a broader change in pituitary medicine away from a single-solution mindset. - Dr. Rao frames precision medicine as choosing the safest and most effective option for each patient, not simply using the newest technology. - His comments also point to a practical reality: pituitary tumors can demand coordinated decisions across brain, hormone and vision specialists. - The research references included in the release are being used to support the idea that individualized care improves outcomes and should guide treatment planning.

What's next: - Patients with suspected pituitary adenomas are being encouraged to seek specialist evaluation early, especially if they have visual changes or hormonal symptoms. - Long-term care will likely continue to rely on MRI surveillance, hormone testing, vision checks, medication changes and multidisciplinary review. - Dr. Rao says the goal is not just tumor removal, but preserving vision, restoring hormonal balance when possible and improving quality of life over time.

The bottom line: - Pituitary adenoma care is increasingly a team sport, and the best outcomes appear to come from tailoring treatment to the individual rather than defaulting to surgery first.